Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
rubber dildos.
Popular Articles

Jellyfish Shed Fluorescent Light On How The Brain Works
New research offers prospect of watching the brain as it learns. Scientists at the University of Leicester are developing new ways of studying how brain cells work -thanks to jellyfish!
diet pills
Federal Program Cracks Down On Medicare Fraud In Houston
A federal program targets Medicare fraud in the Houston area as news of three cases representing at least $35 million in false claims emerged within the past week. The Houston Chronicle reports on the three cases, noting: "These Houston-area scams alleged in two FBI complaints and one Montgomery County indictment were among six reported nationally in a single week - representing at least $285 million in false billings, records showed. "This is an astounding amount," said Houston"s FBI spokeswoman Pat Villafranca. The $285 million is more than four times the amount stolen during robberies of U.S. banks during all of 2008, she said. This month, Houston became the fourth metropolitan area - joining Miami, Los Angeles and Detroit - to create a ramped-up fraud strike force. It goes by the acronym "HEAT," Health Care Fraud Prevention and Enforcement Action Team."
News of the day
NCPA To Congress: Health Reform Should Empower Community Pharmacies To Improve Patient Outcomes, Reduce Costs
National Community Pharmacists Association (NCPA) Executive Vice President and CEO, Bruce T. Roberts, RPh testified today before the U.S. House Energy and Commerce Subcommittee on Health, offering four different recommendations to strengthen a health care reform proposal currently working its way through Congress.
Health Insurance

IPS Examines Need For New Drugs To Treat Neglected Tropical Diseases

Inter Press Service News Agency examines the shortcomings of treatments for neglected tropical diseases - which, according to the Drugs for Neglected Diseases Initiative (DNDi), account "for 12 percent of the global disease burden," and 1.3 percent of the new drugs developed between 1975 to 2004. "The diseases in question account for the deaths of 500,000 people annually, mostly in sub-Saharan Africa, but drug development is biased towards the prospect of high profits, which diseases of the poor like sleeping sickness and visceral leishmaniaisis are unable to offer," IPS writes. "The pharmaceutical industry does not see neglected diseases as a market, because these diseases affect poor people with few res. Therefore they are not a big market," Marcel Tanner, chairman of the DNDi board of directors, told IPS during a meeting last month in Nairobi to discuss new ways to tackle NTDs. "Existing therapies [for neglected tropical diseases] are often toxic, prohibitively costly and difficult to administer," and overwhelm health personnel, IPS writes. The article also addresses efforts to prevent the spread of neglected tropical diseases, through the distribution of insecticide-treated nets and improved sanitation (Mulama, 7/6). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009